174 related articles for article (PubMed ID: 1735696)
21. Effects of local hyperthermia on the tissue levels and toxicity of three radiosensitizers in mice.
Tamuelvicius P; George KC; Rücker A; Streffer C
Int J Hyperthermia; 1992; 8(3):321-8. PubMed ID: 1607737
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
Eifel PJ; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
[TBL] [Abstract][Full Text] [Related]
23. Clinical trials of radiosensitizers: what should we expect?
Brown JM
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
[TBL] [Abstract][Full Text] [Related]
24. Azomycin riboside: a new radiosensitizer.
Pedersen JE; Barron G; Chapman JD
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
[TBL] [Abstract][Full Text] [Related]
25. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
White R; Workman P; Owen L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
[TBL] [Abstract][Full Text] [Related]
26. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics.
Sasai K; Iwai H; Yoshizawa T; Nishimoto S; Shibamoto Y; Oya N; Shibata T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):579-82. PubMed ID: 8005818
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic transforming potential of nitroimidazole radiosensitizers.
Hall EJ; Hei TK
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1231-4. PubMed ID: 2523882
[TBL] [Abstract][Full Text] [Related]
28. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
29. Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides.
Bonnet M; Hong CR; Wong WW; Liew LP; Shome A; Wang J; Gu Y; Stevenson RJ; Qi W; Anderson RF; Pruijn FB; Wilson WR; Jamieson SMF; Hicks KO; Hay MP
J Med Chem; 2018 Feb; 61(3):1241-1254. PubMed ID: 29253343
[TBL] [Abstract][Full Text] [Related]
30. [Recent advances in hypoxic cell radiosensitizer].
Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
[TBL] [Abstract][Full Text] [Related]
31. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
[TBL] [Abstract][Full Text] [Related]
32. Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
Eifel PJ; Brown DM; Lee WW; Brown JM
Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1513-9. PubMed ID: 6629891
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of artificial lung metastases by misonidazole.
Rockwell S; Nierenburg M; Irvin CG
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
[TBL] [Abstract][Full Text] [Related]
35. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.
Lee FY; Workman P
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1627-30. PubMed ID: 6237080
[TBL] [Abstract][Full Text] [Related]
36. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and subcellular localization of radiosensitizers.
Stratford MR
BJR Suppl; 1992; 24():100-4. PubMed ID: 1290683
[No Abstract] [Full Text] [Related]
38. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
39. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
Hei TK; Geard CR; Osmak RS; Hall EJ
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissue.
Sasai K; Shibamoto Y; Takahashi M; Ito T; Nishimoto S; Abe M
Int J Radiat Biol; 1990 May; 57(5):971-80. PubMed ID: 1970998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
